日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

An RNA vaccine against adrenomedullin reduces angiogenesis and tumor burden in a syngeneic metastatic melanoma mouse model

针对肾上腺髓质素的RNA疫苗可减少同源转移性黑色素瘤小鼠模型中的血管生成和肿瘤负荷。

Srdan Tadic,Laura Ochoa-Callejero,Judit Narro-Íñiguez,Josune García-Sanmartín,Alfredo Martínez

An RNA vaccine against adrenomedullin reduces angiogenesis and tumor burden in a syngeneic metastatic melanoma mouse model

针对肾上腺髓质素的RNA疫苗可减少同源转移性黑色素瘤小鼠模型中的血管生成和肿瘤负荷。

Srdan Tadic ,Laura Ochoa-Callejero ,Judit Narro-Íñiguez ,Josune García-Sanmartín ,Alfredo Martínez

Preclinical Evaluation of PTK7-Targeted Radionuclide Therapy.

PTK7靶向放射性核素疗法的临床前评价

Lindland Kim, Westrøm Sara, Dragovic Srdan M, Li Ruth Gong, Malenge Marion Masitsa, Ho Betty, Juzeniene Asta, Bønsdorff Tina Bjørnlund

A DNA Vaccine Against Proadrenomedullin N-Terminal 20 Peptide (PAMP) Reduces Angiogenesis and Increases Lymphocyte and Macrophage Infiltration but Has No Effect on Tumor Burden in a Mouse Model of Lung Metastasis.

针对前肾上腺髓质素 N 端 20 肽 (PAMP) 的 DNA 疫苗可减少血管生成并增加淋巴细胞和巨噬细胞浸润,但对肺转移小鼠模型中的肿瘤负荷没有影响

Raju Tom Kalathil, Tadic Srdan, Garrido Pablo, Ochoa-Callejero Laura, Narro-Íñiguez Judit, García-Sanmartín Josune, Martínez Alfredo

A Stable RNA Vaccine Against the Regulatory Peptide Adrenomedullin Reduces Angiogenesis and Tumor Burden in a Subcutaneous Melanoma Model Without Inducing an Immunosuppressive Tumor Microenvironment

针对调节肽肾上腺髓质素的稳定RNA疫苗可在皮下黑色素瘤模型中减少血管生成和肿瘤负荷,且不会诱导免疫抑制性肿瘤微环境。

Srdan Tadic ,Josune García-Sanmartín ,Judit Narro-Íñiguez ,Alfredo Martínez

Antigen targeting and anti-tumor activity of a novel anti-CD146 (212)Pb internalizing alpha-radioimmunoconjugate against malignant peritoneal mesothelioma.

新型抗CD146(212)Pb内化α放射免疫缀合物对恶性腹膜间皮瘤的抗原靶向性和抗肿瘤活性

Lindland Kim, Malenge Marion Masitsa, Li Ruth Gong, Wouters Roxanne, Bønsdorff Tina Bjørnlund, Juzeniene Asta, Dragovic Srdan M

Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis

在接受莫美替尼或鲁索替尼治疗的骨髓纤维化患者中,骨髓纤维化的变化与疗效结果无关。

Oh, Stephen T; Verstovsek, Srdan; Gupta, Vikas; Platzbecker, Uwe; Devos, Timothy; Kiladjian, Jean-Jacques; McLornan, Donal P; Perkins, Andrew; Fox, Maria Laura; McMullin, Mary Frances; Mead, Adam J; Egyed, Miklos; Mayer, Jiri; Sacha, Tomasz; Kawashima, Jun; Huang, Mei; Strouse, Bryan; Mesa, Ruben

Structure-Guided Approach for the Development of MUC1-Glycopeptide-Based Cancer Vaccines with Predictable Responses

结构引导方法开发具有可预测反应的基于 MUC1 糖肽的癌症疫苗

Iris A Bermejo, Ana Guerreiro, Ander Eguskiza, Nuria Martínez-Sáez, Foivos S Lazaris, Alicia Asín, Víctor J Somovilla, Ismael Compañón, Tom K Raju, Srdan Tadic, Pablo Garrido, Josune García-Sanmartín, Vincenzo Mangini, Ana S Grosso, Filipa Marcelo, Alberto Avenoza, Jesús H Busto, Fayna García-Martín

Symptomatic benefit of momelotinib in patients with myelofibrosis: Results from the SIMPLIFY phase III studies

莫美替尼治疗骨髓纤维化患者的症状获益:SIMPLIFY III期研究结果

Mesa, Ruben A; Hudgens, Stacie; Floden, Lysbeth; Harrison, Claire N; Palmer, Jeanne; Gupta, Vikas; McLornan, Donal P; McMullin, Mary F; Kiladjian, Jean-Jaques; Foltz, Lynda; Platzbecker, Uwe; Fox, M Laura; Mead, Adam J; Ross, David M; Oh, Stephen T; Perkins, Andrew; Leahy, Michael F; Deheshi, Samineh; Donahue, Rafe; Klencke, Barbara J; Verstovsek, Srdan

GLI1 activates pro-fibrotic pathways in myelofibrosis fibrocytes

GLI1 激活骨髓纤维化成纤维细胞中的促纤维化途径

Taghi Manshouri #, Ivo Veletic #, Ping Li, C Cameron Yin, Sean M Post, Srdan Verstovsek, Zeev Estrov